Mapping the Scientific Landscape of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Obesity Treatment
Year: 2025
Type: dissertation
Abstract: This thesis investigates the evolution of scientific literature on GLP-1 and dual GLP-1/GIP receptor agonists for obesity treatment between 2010 and 2024. Using data retrieved from OpenAlex and processed in R, the study applies scientometric techniques and sentiment analysis to assess publication trends, institutional and geographic contributions, and the influence of industry-affiliated research. A comparative sentiment analysis was performed on industry versus non-industry publications, revealing notable tonal discrepancies, particularly for Tirzepatide, where early literature was more positive in industry-sponsored studies. Additionally, author-level metrics such as publication counts, citations, and h-indexes were used to evaluate individual contributions to the field. Results highlight a research landscape dominated by the United States and Denmark, reflecting the influence of pharmaceutical leaders Eli Lilly and Novo Nordisk. The findings underscore the dual role of scientific publishing as both a vehicle for evidence generation and a strategic tool for shaping drug narratives. Limitations include the exclusion of studies due to missing metadata and the short observation window for newly approved therapies. Future research should update the analysis as more longitudinal and real-world data become available, particularly to assess long-term safety, efficacy, and scientific discourse evolution.
Author: Santos, Beatriz Rodrigues dos
Institution: Universidade Nova de Lisboa
Language: English
Subfield: Library and Information Sciences
Field: Social Sciences
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W7112789488
